Sveriges mest populära poddar
CME in Minutes: Education in Primary Care
Hälsa och motionMedicin

Paul Gissen, MD, PhD - A Journey Through Metachromatic Leukodystrophy: From Diagnosis to Clinical Care

14 min•5 februari 2025
Please visit answersincme.com/TDH860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in metabolic diseases discusses metachromatic leukodystrophy (MLD). Upon completion of this activity, participants should be better able to: Explain the clinical burden and unmet needs in MLD; Describe the signs and symptoms of MLD to facilitate early diagnosis and intervention; and Outline potential strategies to optimize outcomes for patients with MLD.

Fler avsnitt av CME in Minutes: Education in Primary Care

Visa alla avsnitt av CME in Minutes: Education in Primary Care
Guidance on Menopause-Related Vasomotor Symptom Management: A Focus on Neurokinin-Targeted Treatment Options
•27 min
Reducing Cardiometabolic Risk: What Cardiovascular Outcomes Trials Tell Us About Incretin-Based Therapies
•16 min
Advancing Secondary Stroke Prevention: How the Latest Evidence Informs Team-Based Practice
•1 tim 2 min
Early Defense: Answering Key Questions About the Science and Strategy of RSV Prevention in Infants
•20 min
Advancing Cardio-Kidney-Metabolic Care in Internal Medicine: Evidence-Based Guidance for Incorporating Nonsteroidal MRAs
•1 tim 8 min
Secondary Stroke Prevention Today and Tomorrow: Where Evolving Antithrombotic Strategies May Fit Into Hospitalist Care
•1 tim 1 min
Test, Treat, Repeat: Closing Persistent Gaps in HCV Care
•21 min
The Next Era of CKD Management in T1D: Evolving Care Strategies to Improve Patient Outcomes
•19 min
Taking the Long View on DME Management: Practical Approaches With Long-Acting Anti-VEGF Agents
•20 min
From Screening to Specialized Care: Navigating Key Questions in Alpha-1 Antitrypsin Deficiency–Associated Liver Disease
•16 min

CME in Minutes: Education in Primary Care med Answers in CME finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.